For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for The Charles Schwab Corporation (SCHW) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-10-07): Designation Watch · Gem Score +35 (−100…+100 Quality+Value blend) · Quality 72 · Value 10 · Sentiment 36 (timing only, not weighted) · Composite fair value $182.31 vs $104.62 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
The Charles Schwab Corporation
SCHW NYSEThe Charles Schwab Corporation is a U.S. financial services company that provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. Through its operating businesses, The Charles Schwab Corporation serves individual investors, retirement plan participants, independent financial advisors, and institutional clients with tools and services for trading, investing, cash management, and long-term account administration. Its Investor Services segment focuses on retail brokerage, banking, trust, and retirement-related services, while its Advisor Services segment supports independent registered investment advisors and other professional wealth managers with custodial, trading, and operational solutions. The Charles Schwab Corporation plays a central role in the U.S. investment-services market by combining brokerage access, banking capabilities, and advisory infrastructure under one platform.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 4.65
Total Equity: $49.43B
Shares: 1,903,655,914
Total Debt: $31.01B
Cash: $46.03B
EBITDA: N/A
Total Debt: $31.01B
Cash: $46.03B
Revenue: $23.92B
Revenue: $23.92B
Revenue: $23.92B
Total Equity: $49.43B
Tax Rate: 22.8%
Equity: $49.43B
Total Debt: $31.01B
Cash: $46.03B
Current Liabilities: N/A
Long-Term Debt: $22.20B
Total Debt: $31.01B
Total Equity: $49.43B
Shares: 1,903,655,914
Shares: 1,903,655,914
CapEx: -$548.00M
Shares: 1,903,655,914
Stock Price: $109.29
Net Income: $8.85B
Industry Benchmarks
Income Statement (Annual)
Last updated: Sep 4, 2026 11:00pm (32d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $18.5B | $20.8B | $18.8B | $19.6B | $23.9B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | $5.9B | $6.4B | $6.7B | $6.4B | $6.9B |
| Operating Income | — | — | — | — | — |
| Net Income | $5.9B | $7.2B | $5.1B | $5.9B | $8.9B |
| EBITDA | — | — | — | — | — |
| EPS | $2.84 | $3.52 | $2.55 | $3.00 | $4.67 |
| EPS (Diluted) | $2.83 | $3.50 | $2.54 | $2.99 | $4.65 |
Balance Sheet (Annual)
Last updated: Sep 4, 2026 11:00pm (32d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $63.0B | $40.2B | $43.3B | $42.1B | $46.0B |
| Total Current Assets | — | — | — | — | — |
| Total Assets | $667.3B | $551.8B | $493.2B | $479.8B | $491.0B |
| Current Liabilities | — | — | — | — | — |
| Long-Term Debt | $18.9B | $20.8B | $26.1B | $22.4B | $22.2B |
| Total Liabilities | $611.0B | $515.2B | $452.2B | $431.5B | $441.6B |
| Total Equity | $56.3B | $36.6B | $41.0B | $48.4B | $49.4B |
| Retained Earnings | $26.0B | $31.1B | $33.9B | $37.6B | $44.1B |
Cash Flow (Annual)
Last updated: Sep 4, 2026 11:17pm (32d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2.1B | $2.1B | $19.6B | $2.7B | $9.3B |
| Capital Expenditure | -$916.0M | -$971.0M | -$700.0M | -$620.0M | -$548.0M |
| Free Cash Flow | $1.2B | $1.1B | $18.9B | $2.1B | $8.8B |
| Acquisitions (net) | — | — | — | — | — |
| Net Debt Issued / (Repaid) | $5.2B | $1.9B | — | — | — |
| Dividends Paid | -$1.8B | -$2.1B | -$2.3B | -$2.3B | -$2.3B |
| Stock Buybacks | $0 | -$3.4B | -$2.8B | $0 | -$7.3B |
| Net Change in Cash | $22.8B | -$34.6B | $15.8B | -$9.0B | $4.1B |
Growth Trends (YoY %)
Last updated: Sep 4, 2026 11:00pm (32d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +12.1% | -9.3% | +4.1% | +22.0% |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | — | — | — | — |
| Net Income Growth | +22.7% | -29.5% | +17.3% | +49.0% |
| EBITDA Growth | — | — | — | — |
Dividend History (Last 20)
Last updated: Sep 4, 2026 11:00pm (32d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-08-14 | $0.32 | — | — | — |
| 2026-05-08 | $0.32 | — | — | — |
| 2026-02-13 | $0.32 | — | — | — |
| 2025-11-14 | $0.27 | — | — | — |
| 2025-08-08 | $0.27 | — | — | — |
| 2025-05-09 | $0.27 | — | — | — |
| 2025-02-14 | $0.27 | — | — | — |
| 2024-11-08 | $0.25 | — | — | — |
| 2024-08-09 | $0.25 | — | — | — |
| 2024-05-09 | $0.25 | — | — | — |
| 2024-02-08 | $0.25 | — | — | — |
| 2023-11-09 | $0.25 | — | — | — |
| 2023-08-10 | $0.25 | — | — | — |
| 2023-05-11 | $0.25 | — | — | — |
| 2023-02-09 | $0.25 | — | — | — |
| 2022-11-09 | $0.22 | — | — | — |
| 2022-08-11 | $0.22 | — | — | — |
| 2022-05-12 | $0.20 | — | — | — |
| 2022-02-10 | $0.20 | — | — | — |
| 2021-11-10 | $0.18 | — | — | — |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Computed 2026-09-17 18:48A +1σ run of quarters pays +27%; a −1σ run costs 35%. Ratio 0.8:1 (μ 16.2%, σ 11.0% , 16 pairs).
Older method (repeat-worst-quarter): 3.5 : 1
| Case | Growth | Margin | Fair value | vs price ($104.62) |
|---|---|---|---|---|
| Bull — recovery | +29% | 35.0% | $139.51 | +33% |
| Base — stabilizes | +19% | 35.0% | $105.42 | +1% |
| Bear — keeps slipping | +10% | 33.0% | $74.36 | -29% |
| Stress — last quarter repeats | +16% | 35.0% | $94.60 | -10% |
| Upside — a +1σ run of quarters (v2) | +27% | 35.0% | $132.38 | +27% |
| Stress — a −1σ run of quarters (v2) | +5% | 35.0% | $67.83 | -35% |
Narrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-09-17 16:28The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
Independent read first: the quarterly trajectory is genuinely impressive. Revenue climbed from $4.85B (Q3'24) to $7.07B (Q2'26) — 46% growth in seven quarters — while net margin expanded from 29.0% to 39.6%. TTM revenue is roughly $26.0B with NI around $10.1B, putting real P/E closer to ~18x on $181.9B cap, consistent with the tile. This is not a fallen angel; this is a franchise firing on all cylinders as TD Ameritrade cost synergies compound with a still-elevated rate deck. Sequential revenue acceleration (+3.6%, +2.2%, +9.1% QoQ across the last three quarters) contradicts the "decelerating" tag in Secondary Signals — that flag looks mechanically wrong.
Where I disagree with the synthesis: a $199 fair value (+90%) is aggressive extrapolation. Applying 20x to run-rate NI of ~$11.2B (annualizing Q2'26) gets ~$224B equity value, or roughly $129/share — call it 20-25% upside, not 90%. The DCF-implied number assumes both current NIM AND continued double-digit revenue growth persist through terminal, which double-counts the cycle. The Thesis Evaluation's -11 score correctly flags the tension: the bear case on NIM normalization is real — sweep cash yields compress mechanically as the Fed cuts, and Schwab's earnings are more rate-levered than the bull narrative admits. But the bear thesis of "cash flow quality deterioration" is weakly supported when FCF ran $8.76B in 2025 against $8.85B NI — 99% conversion is not deterioration.
The contrarian argument worth taking seriously: at 39.6% net margin and 20.3% YoY revenue growth, Schwab is at peak-cycle earnings. History says this reverses. In 2023, on $18.84B revenue, NI was only $5.07B (26.9% margin) — that's what a compressed-NIM Schwab looks like. If rates normalize to 3% and sweep balances stay flat, TTM earnings could revert toward $7-8B, making the stock ~23-26x normalized, not 18x. The "fallen angel discount" narrative is stale — SCHW at $104 is up substantially from the 2023 SVB-contagion lows near $45 and is trading in line with, not below, a reasonable through-cycle multiple. The insider activity reinforces this: option-exercise-and-sell patterns are routine, but the pure S-Sale lines (117,000 shares on 8/24, 9,175 on 8/26) with no offsetting buys contradict the "Net Insider Buying" flag in Secondary Signals — another data label that looks miscoded.
Balance sheet is fine but not a fortress for a broker-dealer: $46B cash vs $31B debt, $49.4B equity supporting a much larger balance sheet (ROA of 2.07% implies ~$490B assets). Held-to-maturity securities losses — the 2023 crisis trigger — aren't shown here but remain the tail risk if deposits flee again in a rate shock. The Pre-Flight thesis correctly identifies the three embedded expectations (sustained NIM, moat durability, RIA growth); I'd argue the market is pricing these more or less fairly, not skeptically. The 18x TTM multiple is reasonable-to-full for a financial at peak margins, not a bargain. The synthesis model appears to be treating cyclical peak earnings as sustainable base rates — a classic error at this point in a rate cycle.
GPT Reading
Schwab’s raw numbers read much better than the hand-wringing narrative. On the trailing twelve months through June 2026, revenue is about $26.0 billion and net income about $10.1 billion, implying a 38.8% net margin and roughly 20% year-over-year growth versus the prior TTM window of about $21.6 billion revenue and $7.3 billion net income. What stands out most is not just growth, but the cadence: quarterly revenue has risen from $4.85 billion in 2024-09 to $7.07 billion in 2026-06, while net margin expanded from 29.0% to 39.6%. That is not a business limping through rate normalization; it is a business showing operating leverage and balance-sheet earnings power at the same time. Against a $181.9 billion market cap, the stock trades at 18.3x TTM earnings, which is not cheap in a bank context but looks reasonable for a franchise producing a 20.3% ROE, an 8.76 billion annual free cash flow stream, and visibly improving profitability.
The valuation argument for “dramatic undervaluation” overreaches, though. A 7.1x sales multiple and 3.7x book value already give Schwab credit for being much better than an ordinary financial. The market is not asleep here. At $104.62, investors are paying for a premier wealth and custody platform with structurally higher returns, not a cyclical recovery stub. I think that is broadly correct. The annual history also warns against simply capitalizing today’s run rate as if it were linear: revenue was $20.76 billion in 2022, then fell to $18.84 billion in 2023 before recovering to $19.61 billion in 2024 and $23.92 billion in 2025. Schwab is a high-quality financial compounder, but still one whose earnings are materially shaped by spread income, cash sorting, and the rate backdrop. That makes the leap from 18x earnings to some DCF-derived $180-$200 fair value hard to accept. The stock deserves a premium, just not an anything-goes premium.
What I think the numbers actually say is simpler: the business has repaired faster than bears expected, and the shares have already repriced a lot of that repair. Net cash versus debt is favorable on the face of it, with $46.0 billion cash against $31.0 billion debt, and the payout ratio of 23.8% leaves plenty of room for dividend growth or capital retention. The real attraction is franchise quality plus earnings resilience: even after the 2023 disruption, Schwab is now generating quarterly profits of $2.4-$2.8 billion with very little capital intensity, only $548 million of capex against $9.3 billion of operating cash flow. That supports a premium multiple. But a premium multiple on peak-ish margins and strong rate-sensitive earnings usually leads me to “good company, fair stock,” not “double from here.”
The best case against my read is that I may be underestimating how durable this earnings step-up is. If the TTM revenue base near $26 billion is not a rate-cycle gift but the new normalized earnings power of the post-TD Ameritrade franchise, then 18.3x earnings is too low for a dominant platform with 20% ROE, modest leverage, and recurring client asset economics. The quarterly sequence does support that bullish view: each of the last eight quarters showed both revenue and earnings improvement, and the latest quarter’s 39.6% margin suggests continued upside rather than plateau. A bull would also argue that 3.7x book is justified if Schwab can sustainably earn 18%-20% on equity, because that implies a very attractive spread over cost of capital even in a lower-rate world. I weigh this less heavily because financial firms rarely get to keep both elevated spread income and elevated valuation multiples when the cycle turns; something usually normalizes.
What would change my mind is concrete evidence that today’s earnings power is either more fragile or more durable than I assume. On the bullish side, if revenue holds above $6.8-$7.0 billion per quarter for the next few quarters while net margin stays in the high-30s and annualized net income remains above $10 billion despite a less favorable rate backdrop, I would move to clearly undervalued and support a price north of $120. On the bearish side, if quarterly revenue slips back toward the low-$6 billions and margin retraces toward 34%-35%, then today’s 18x multiple is too generous and the stock would look expensive above $95-$100. For now, the operating data are strong enough to keep me positive on the business, but not so mispriced that I can call the shares a major bargain.
Grok Reading
The raw trajectory is unambiguous and better than a “mature earner” label usually implies. Trailing-twelve-month revenue through 2026-06-30 sits at roughly $26.0B (sum of the four most recent quarters), up from about $21.6B in the prior-year window, a ~20% lift that matches the reported recent revenue YoY. Net income over the same span is approximately $10.1B versus ~$7.3B a year earlier, producing a mid-to-high-30s net margin that has marched steadily higher: 29% in 2024-09-30, 34–36% through mid-2025, and 38–40% in the latest three prints, culminating at 39.6% on $7.07B of revenue in the June 2026 quarter. Sequential revenue has risen every quarter for two years, and the most recent step-up (6.48 → 7.07) is the largest absolute jump in the series. Annual figures confirm the inflection—2025 revenue $23.9B and NI $8.85B versus the 2023 trough of $18.8B / $5.1B—while free-cash-flow conversion remains pristine ($8.76B FCF on $9.31B operating cash flow against negligible capex). The balance sheet is net-cash comfortable ($46B cash versus $31B debt, equity $49B, D/E 0.45), ROE prints 20%, and the stock at $104.62 screens at 18.3× TTM earnings, 3.7× book and 7.1× sales. That is not a distressed multiple for a franchise still expanding both top line and margins at this rate; the operational story is one of post-integration scale finally showing up in the P&L with unusual clarity.
I discard the valuation synthesis that spits out $182–$199 fair value (90% upside). Capitalizing $10B of current earnings at 30–34× would price a hyper-growth software name, not a capital-markets incumbent whose own archetype engine correctly tags it mature_earner. The 18× multiple already embeds solid execution; it does not embed a free lunch. Insider tapes are likewise mis-signaled: the last ten filings are overwhelmingly option exercises followed by immediate sales plus a gift—classic liquidity events, not “net buying.” Where the numbers and the models diverge most usefully is exactly here: earnings power and cash conversion are real and improving, yet the mechanical “undervalued by half” claim is an artifact, not a thesis.
The strongest counter-argument is that the entire margin and earnings acceleration is still a rate-cycle and cash-sweep phenomenon that has not yet faced a full normalization. Schwab’s model monetizes idle client cash; once the Fed’s path compresses net interest margin in earnest, the 39% net margin and the 44% earnings CAGR become non-recurring. Revenue-confidence already flags a decelerating quarterly trend beneath the headline YoY, PS of 7.1× is rich for any balance-sheet-driven financial, and ROA of only 2.1% reminds you how much leverage and deposit mix sit underneath the glossy ROE. The narrative layer’s bear case—that Schwab is sliding toward a low-growth wealth utility whose 2021-era multiple was a zero-rate delusion—fits the same data if the next four quarters simply flatten at $6.5–7.0B of revenue and margins drift back toward the low 30s. In that world 15× forward earnings and a mid-90s stock price are plausible, and today’s 18× looks like the wrong side of the trade. I weigh this seriously but secondary: the June 2026 quarter’s sequential acceleration and continued margin expansion argue the company is still taking share and harvesting TD synergies faster than pure NIM math would predict. Still, the bear case is coherent and the valuation models that ignore it are not.
Two clean sequential quarters of revenue decline or net margin sustained below 35% would flip me to fairly valued or worse; conversely, another two quarters above $7B with explicit commentary that NNA and net interest income are holding under lower rates would push conviction higher and fair value toward the low $130s. Until then the stock at $104.62 is a high-quality compounder priced for adequacy rather than excellence.
Qwen Reading local experiment · off-panel
The most glaring contradiction in this briefing is the Valuation Synthesis model’s claim that Schwab is trading at a 90% discount to fair value ($199.17 vs. $104.62). This is a computational hallucination that ignores the fundamental arithmetic of the balance sheet. Schwab’s market cap is $181.86B, but its total equity is only $49.43B. A Price-to-Book ratio of 3.69x is not a "deep value" setup; it is a premium multiple for a financial services firm. The model likely confused Enterprise Value with Equity Value or applied a DCF multiple to a company with significant debt and negative working capital dynamics typical of brokerages. When you strip away the algorithmic noise, the data tells a story of a high-quality, high-margin machine that is currently priced for perfection, not distress. The net margin expansion from 29% in Q3 2024 to 39.6% in Q2 2026 is impressive, but it is driven by a revenue base that has grown from $4.85B to $7.07B in just two years. This 45% revenue surge is the engine of the current valuation, not a hidden gem waiting to be discovered.
The "fallen-angel" narrative and the "undervalued" verdict are mutually exclusive and both appear flawed. The market is not pricing Schwab as a broken utility; it is pricing it as a growth compounder. The 18.3x P/E is reasonable for a company growing earnings at a 44% CAGR, but it is not cheap. The real risk is not that the market is wrong about the discount, but that the market is right about the sustainability. The insider transaction data is a red flag that the "Net Insider Buying" secondary signal completely misses. In August and September 2026, insiders executed option exercises and immediately sold the shares (e.g., 74,388 shares exercised and sold on Aug 28; 117,000 shares sold on Aug 24). This is classic monetization behavior, not accumulation. When insiders are cashing out at $104.62, they are signaling that the current price is at or above their perceived fair value, directly contradicting the AI model’s $199 target.
The strongest case against my bearish lean is the sheer quality of the cash flow. Operating cash flow of $9.31B against net income of $8.85B indicates excellent earnings quality, and the free cash flow of $8.76B is robust. The balance sheet is fortress-like with $46B in cash against $31B in debt. If the TD Ameritrade integration synergies are real, as the bull case argues, then the 20% ROE is sustainable even in a lower-rate environment. The "mature earner" classification with 0.88 confidence is actually the most accurate label here. Schwab is not a high-growth tech stock; it is a cash cow with a moat. The 18.6% revenue CAGR is likely a peak-cycle number driven by the post-2022 rate environment and the TD integration, not a secular trend. The "deceleration" noted in the revenue confidence signal is the key data point the models are ignoring.
What would change my mind is a clear deceleration in the revenue growth rate below 10% YoY combined with a stabilization of net margins in the 35-38% range. If Schwab can maintain 38% margins while growing revenue at 10%, the 18x P/E is justified. However, if the revenue growth drops to single digits and margins compress to 30% due to NIM normalization, the stock is overvalued. The specific event to watch is the next earnings report’s commentary on "non-interest income" growth. If the growth is driven by market volatility (trading commissions) rather than structural AUM growth (custody fees), the valuation is fragile. The insider selling at current levels suggests that management sees the peak of the cycle.
The "Market Forces" signal being unavailable is a significant gap, but the "Macro Headwinds" signal is telling. The Fed is likely to cut rates, which will compress Schwab’s net interest income. The 39.6% net margin is unsustainable in a zero-rate environment. The 2021 peak valuation was indeed a "zero-rate delusion," and the current price is a reversion to a more normal, but still premium, multiple. The 47% discount to intrinsic value cited in the narrative is a fantasy; the intrinsic value is likely closer to the current price, not $199. The stock is fairly valued, perhaps slightly overvalued given the insider monetization and the macro headwinds.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Revenue climbed from $19.0B (2022) to $26.0B (TTM 6/2026), a ~37% expansion, with net income rising from $6.30B to $10.10B and FCF averaging roughly $10B annually since 2023. OCF/NI at 1.52x and negative accruals (-0.8% of assets) indicate reported earnings are backed by real cash. The 2024 dip (NI $4.86B) reflected the well-known sweep-cash/deposit-migration pressure from the rate cycle; the 2025-2026 rebound shows the franchise absorbed it. Diluted share count fell from 1.90B to 1.77B (-1.8% CAGR) with buybacks running ~688% of SBC and SBC only 1.3% of revenue - genuine per-share concentration, not optical. Liquid cash of $40.6B against $22.7B debt (net cash $17.9B) gives the parent ample flexibility, though as a bank-broker the balance sheet is inherently leveraged and the Altman Z of 0.41 is a model artifact (Z is not meaningful for financials). Insider tape is dominated by option-exercise-and-sell and founder gifting/trimming - not a red flag for a mature exec team, but not the conviction buying the summary label suggests. The business looks solidly healthy: scaled network effects in custody/brokerage, sticky client assets, improving operating leverage, and disciplined capital return.
Verify before trusting this (5)
- Client asset growth, net new asset trend, and sweep-cash balances in the latest 10-Q to confirm the deposit-migration headwind is truly behind them
- Bank-subsidiary regulatory capital ratios (CET1, Tier 1 leverage) and AOCI mark on the HTM/AFS securities book
- Segment mix of the $26B revenue between NII, asset-management fees, and trading to gauge durability
- Terms and remaining authorization of the buyback program and any preferred-stock redemptions
- Whether founder Charles Schwab's gifting/selling pattern reflects estate planning vs a change in view
The e2e composite FV of $182 and signal-adjusted $199 imply ~74-90% upside from $104.62, which fails the smell test for a mature, well-covered $182B franchise - that kind of dislocation does not sit on a mega-cap broker-bank in plain sight. The anchored-PE at $144 is the more credible pin: a strong, scaled, cash-generative business earning ~$10B with a shrinking share count reasonably deserves a mid-teens multiple, putting deserved value in the $140-160 zone. Against $104.62 that is roughly a 30-40% gap - meaningful, but not a screaming dislocation, and partly compensation for real structural rate sensitivity and NIM uncertainty flagged in the bear case.
Verify before trusting this (5)
- Forward NIM guidance and cash-sorting trajectory in the next 10-Q
- Bank Supplemental Funding paydown pace and its earnings drag
- Client cash levels and sweep deposit trends
- Buyback pace and remaining authorization
- Any regulatory capital changes affecting payout capacity
The non-fundamental pressure on SCHW is net positive right now. The active news flow is unusually favorable: a record August of $64.8B in net new assets, margin balances up 92% YoY, and a headline-grabbing Anthropic/Claude rollout to 16,000 RIAs that plugs Schwab directly into the hottest narrative in markets (AI agents in wealth management). That gives a 'fallen-angel' name a fresh, forward-looking story just as it heads into a scheduled Oct 15 Fall Business Update catalyst. Momentum is strong-positive and beta is only 0.75, so the risk-off market tape (VIX 17.7, S&P -3.2% from highs) lands softly on this name relative to high-beta growth. Offsets are real but secondary: a bond-market rout pressuring the muni ETF franchise reminds the tape of Schwab's rate/duration sensitivity, and a $1.3M elder-fraud arbitration loss is a minor reputational nick. Narrative durability is only moderate and cult coefficient is low, so this is a genuine crosswind in Schwab's favor rather than a mania. Net: a moderate tailwind with a catalyst on the calendar.
Verify before trusting this (5)
- Sell-side target revisions in the 24-48h after the Anthropic/AI announcement
- Oct 15 Fall Business Update tone on NIM trajectory and cash sorting
- Whether the muni-ETF outflow story broadens into a wider fixed-income franchise narrative
- Follow-through on monthly net-new-asset prints (does the record August extend?)
- Any rotation into financials if the yield curve steepens further
The world Schwab operates in has shifted from a zero-rate, fee-compressed brokerage market to a positive-carry one: a 5% long rate with an upward-sloping curve makes custodying and intermediating client cash structurally more profitable than it was for a decade, provided the deposit beta stays contained. Simultaneously, wealth is consolidating onto a handful of scaled custodians as independent advisors break away from wirehouses — a secular flow that Schwab is the default recipient of. The offsetting force is that the same high-rate regime makes client cash yield-aware, so every dollar of spread must be defended, and a capital-markets slowdown would hit fees, trading and margin balances at once. Net: the structural backdrop favors scaled custodians, the cyclical backdrop is turning less friendly.
When we made this prediction on Sep 18, 2026, SCHW was $104.88. We expect it to be $134.00 by Mar 2027, and we consider it great value under $95.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Sep 18, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.